USPTO serial 79357024
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical reagents for scientific or research purposes; testing reagents or preparations for non-medical use; biochemicals for scientific or research use, namely, reagents for testing biological samples; assays and reagents for use in genetic research for non-medical purposes; chemical reagents used for DNA sequencer for research purposes; reagent kits comprising DNA primers, enzymes, control materials, calibrators and buffer solutions for use in genetic testing for non-medical purposes; DNA polymerase for scientific or research use; enzymes for scientific or research use; quality control materials, namely, fluid, frozen or lyophilized chemical preparations for testing and calibrating scientific or laboratory apparatus; chemical reference materials for scientific or research use; DNA primers used for genetic testing for scientific or research use; diluents other than for medical or veterinary purposes; buffer solutions for scientific purposes; quality control materials, namely, fluid, frozen or lyophilized chemical preparations for testing and calibrating medical apparatus for medical or veterinary purposes | ACTIVE | — |
| 005 | Diagnostic reagents and diagnostic preparations for medical or veterinary purposes; chemical reagents for medical or veterinary purposes; assays and reagents for use in genetic testing for medical purposes; chemical reagents used for DNA sequencer for medical purposes; reagent kits comprising DNA primers, enzymes, control materials, calibrators and buffer solutions for use in genetic testing for medical purposes; dna polymerase for use in medical analysis; enzymes for medical analysis; chemical reference materials for medical use; DNA primers used for genetic testing for medical purposes; diluents for medical or veterinary use; buffer solutions for medical or veterinary use | ACTIVE | — |
| 009 | Genetic testing apparatus for non-medical purposes; genetic testing apparatus and instruments for scientific, research or laboratory use; gene amplification analyzers for scientific, research or laboratory use; DNA sequencer for scientific, research or laboratory use; biological sample pretreatment apparatus and instruments for scientific, research or laboratory use; cell analysis apparatus and instruments for scientific, research or laboratory use, namely, flow cytometers, flow-based analyzers and image analyzers; protein analysis apparatus and instruments for scientific, research or laboratory use, namely, flow cytometers, flow-based analyzers and image analyzers; pipette tips for scientific, research or laboratory use; microplates for laboratory experiment; * plates for laboratory experiment having a dent to be filled with primers (DNA synthesis) * [ primer-prepacked plates for laboratory experiment ] ; laboratory apparatus and instruments used for genetic testing for scientific, research or laboratory purposes; downloadable computer programs for use in the field of scientific or laboratory analysis; downloadable computer programs for use in the field of medical, clinical or diagnostic analysis; electronic downloadable publications in the nature of magazines and manuals in the field of genetic testing; downloadable computer programs for genetic, cell and protein analysis | ACTIVE | — |
| 010 | Testing apparatus and instruments for medical or clinical use, namely, apparatus for medical diagnostic testing in the fields of genetic testing; diagnostic apparatus and instruments for medical or clinical use, for diagnosing gene mutation; genetic testing apparatus and instruments for medical or clinical use, namely, apparatus for medical diagnostic testing in the field of gene analysis; gene amplification analyzers for detecting gene mutation for medical or clinical use; DNA sequencer for medical or clinical use, namely, for gene analysis; biological sample pretreatment apparatus and instruments for medical or clinical use; measurement sample preparation apparatus and instruments for medical or clinical use; pretreatment apparatus and instruments for genetic testing for medical or clinical use; pipette tips for medical analysis; measuring apparatus and instruments for use in medical analysis for detecting gene mutation; * plates for medical or clinical use having a dent to be filled with primers (DNA synthesis) * [ primer-prepacked plates for medical or clinical use ] | ACTIVE | — |
| 042 | Scientific and technological research in the field of genetic testing; scientific research, scientific analysis, and design relating thereto in the field of genetic testing; design and development of diagnostic reagents; analytical testing services for others, namely, performing genetic testing; testing services to detect or quantify gene mutations, gene variations, gene amplification, gene loss and gene fusion for scientific and research purposes; DNA screening for scientific and research purposes; molecular biomarker testing services for scientific and research purposes; DNA sequencing services for scientific and research purposes; testing services for research in gene analysis; testing and research relating to cell or protein analysis for scientific purposes; providing online non-downloadable computer programs for use in the field of scientific and laboratory analysis; providing online non-downloadable computer programs for use in the field of medical, clinical or diagnostic analysis; providing online non-downloadable computer programs for genetic, cell or protein analysis | ACTIVE | — |
| 044 | Providing medical information in the field of genetic testing; providing medical data/information to healthcare professionals; medical diagnostic testing and reporting services pertaining to the monitoring, diagnosis and treatment of diseases; testing services to provide information regarding disease conditions and disease prevention; diagnostic services, namely, medical diagnostic testing for diseases and disorders | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 2, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 2, 2024 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Jun 23, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 4, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 4, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 4, 2024 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| May 29, 2024 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| May 29, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 13, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 31, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 13, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 13, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 28, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 28, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 27, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 8, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 8, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 24, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 18, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 17, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 17, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 28, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 28, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 28, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 28, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 28, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 11, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 18, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 18, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 10, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 9, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 31, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 3, 2023 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 30, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 14, 2022 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Dec 8, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |